Related Experiment Videos
[The value of Phadiatop screening tests for diagnosing allergic respiratory diseases in children]
C Zychowicz1, E Najberg, H Misiowiec
1Oddziału Izolacyjno-Obserwacyjnego.
Insights
Phadiatop is a highly sensitive and specific in vitro diagnostic test for inhalant allergies in children. This screening tool is recommended for initial respiratory tract diagnosis, outperforming PRIST in accuracy.
Area of Science:
- Allergy diagnostics
- Pediatric respiratory diseases
- Immunological assays
Context:
- 174 children aged 1-16 years with respiratory symptoms underwent testing.
- Conditions included bronchial asthma, obstructive bronchitis, and allergic rhinitis.
- Atopic allergy prevalence was over 93% in the study group.
Purpose:
- To evaluate the diagnostic performance of the Phadiatop test.
- To compare Phadiatop with the PRIST assay for inhalant allergy screening.
- To determine the sensitivity, specificity, and accuracy of Phadiatop in children.
Summary:
- Phadiatop demonstrated high sensitivity (93.5%), specificity (90%), and accuracy (91.4%) in detecting inhalant allergies.
- Compared to PRIST (91.7% sensitivity, 80.3% specificity, 87.4% accuracy), Phadiatop showed superior performance.
- Fewer false negative and false positive results were observed with Phadiatop.
Impact:
- Phadiatop is an effective in vitro screening test for inhalant allergies.
- It is recommended for early stages of respiratory diagnosis in children.
- The test offers improved diagnostic accuracy over PRIST for pediatric allergy screening.
Abstract:
Phadiatop test was performed in 174 children aged between 1 and 16 years (mean: 9 6/12 years) referred to the hospital because of the bronchial asthma, obstructive bronchitis and perennial or seasonal allergic rhinitis. Positive results were obtained in over 93% of children with atopic allergy. Comparing with PRIST, multiple allergen assay proved more sensitive (93.5%), specific (90%), and accurate (91.4%). The same data for PRIST were: 91.7%, 80.3%, 87.4%, respectively. False negative and false positive results were also less frequent than for PRIST. Therefore, Phadiatop, is considered an appropriate screening in vitro diagnostic test for inhalant allergy which should be performed at the beginning of respiratory tract diagnosis.